Literature DB >> 31389987

Non-coding RNAs in cardiovascular cell biology and atherosclerosis.

Francesca Fasolo1, Karina Di Gregoli2, Lars Maegdefessel1,3,4, Jason L Johnson2.   

Abstract

Atherosclerosis underlies the predominant number of cardiovascular diseases and remains a leading cause of morbidity and mortality worldwide. The development, progression and formation of clinically relevant atherosclerotic plaques involves the interaction of distinct and over-lapping mechanisms which dictate the roles and actions of multiple resident and recruited cell types including endothelial cells, vascular smooth muscle cells, and monocyte/macrophages. The discovery of non-coding RNAs (ncRNAs) including microRNAs, long non-coding RNAs, and circular RNAs, and their identification as key mechanistic regulators of mRNA and protein expression has piqued interest in their potential contribution to atherosclerosis. Accruing evidence has revealed ncRNAs regulate pivotal cellular and molecular processes during all stages of atherosclerosis including cell invasion, growth, and survival; cellular uptake and efflux of lipids, expression and release of pro- and anti-inflammatory intermediaries, and proteolytic balance. The expression profile of ncRNAs within atherosclerotic lesions and the circulation have been determined with the aim of identifying individual or clusters of ncRNAs which may be viable therapeutic targets alongside deployment as biomarkers of atherosclerotic plaque progression. Consequently, numerous in vivo studies have been convened to determine the effects of moderating the function or expression of select ncRNAs in well-characterized animal models of atherosclerosis. Together, clinicopathological findings and studies in animal models have elucidated the multifaceted and frequently divergent effects ncRNAs impose both directly and indirectly on the formation and progression of atherosclerosis. From these findings' potential novel therapeutic targets and strategies have been discovered which may pave the way for further translational studies and possibly taken forward for clinical application. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Atherosclerosis; Endothelial cells; Macrophages; Non-coding RNA; Vascular smooth muscle cells; microRNA

Mesh:

Substances:

Year:  2019        PMID: 31389987      PMCID: PMC7967706          DOI: 10.1093/cvr/cvz203

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  207 in total

Review 1.  Molecular mechanisms of long noncoding RNAs.

Authors:  Kevin C Wang; Howard Y Chang
Journal:  Mol Cell       Date:  2011-09-16       Impact factor: 17.970

Review 2.  Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995.

Authors:  M J Davies
Journal:  Circulation       Date:  1996-10-15       Impact factor: 29.690

3.  microRNA-33 Regulates Macrophage Autophagy in Atherosclerosis.

Authors:  Mireille Ouimet; Hasini Ediriweera; Milessa Silva Afonso; Bhama Ramkhelawon; Ragunath Singaravelu; Xianghai Liao; Rachel C Bandler; Karishma Rahman; Edward A Fisher; Katey J Rayner; John P Pezacki; Ira Tabas; Kathryn J Moore
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-04-20       Impact factor: 8.311

4.  MicroRNA-124-3p inhibits collagen synthesis in atherosclerotic plaques by targeting prolyl 4-hydroxylase subunit alpha-1 (P4HA1) in vascular smooth muscle cells.

Authors:  Wei'jia Chen; Fangpu Yu; Mingxue Di; Mengmeng Li; Yifei Chen; Yu Zhang; Xiaolin Liu; Xiaozhen Huang; Mei Zhang
Journal:  Atherosclerosis       Date:  2018-08-26       Impact factor: 5.162

5.  Identification of coordinately regulated microRNA-gene networks that differ in baboons discordant for LDL-cholesterol.

Authors:  Genesio M Karere; Jeremy P Glenn; Shifra Birnbaum; Roy Garcia; John L VandeBerg; Laura A Cox
Journal:  PLoS One       Date:  2019-03-15       Impact factor: 3.240

6.  MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1.

Authors:  Andreas Schober; Maliheh Nazari-Jahantigh; Yuanyuan Wei; Kiril Bidzhekov; Felix Gremse; Jochen Grommes; Remco T A Megens; Kathrin Heyll; Heidi Noels; Michael Hristov; Shusheng Wang; Fabian Kiessling; Eric N Olson; Christian Weber
Journal:  Nat Med       Date:  2014-03-02       Impact factor: 53.440

7.  A promoter-level mammalian expression atlas.

Authors:  Alistair R R Forrest; Hideya Kawaji; Michael Rehli; J Kenneth Baillie; Michiel J L de Hoon; Vanja Haberle; Timo Lassmann; Ivan V Kulakovskiy; Marina Lizio; Masayoshi Itoh; Robin Andersson; Christopher J Mungall; Terrence F Meehan; Sebastian Schmeier; Nicolas Bertin; Mette Jørgensen; Emmanuel Dimont; Erik Arner; Christian Schmidl; Ulf Schaefer; Yulia A Medvedeva; Charles Plessy; Morana Vitezic; Jessica Severin; Colin A Semple; Yuri Ishizu; Robert S Young; Margherita Francescatto; Intikhab Alam; Davide Albanese; Gabriel M Altschuler; Takahiro Arakawa; John A C Archer; Peter Arner; Magda Babina; Sarah Rennie; Piotr J Balwierz; Anthony G Beckhouse; Swati Pradhan-Bhatt; Judith A Blake; Antje Blumenthal; Beatrice Bodega; Alessandro Bonetti; James Briggs; Frank Brombacher; A Maxwell Burroughs; Andrea Califano; Carlo V Cannistraci; Daniel Carbajo; Yun Chen; Marco Chierici; Yari Ciani; Hans C Clevers; Emiliano Dalla; Carrie A Davis; Michael Detmar; Alexander D Diehl; Taeko Dohi; Finn Drabløs; Albert S B Edge; Matthias Edinger; Karl Ekwall; Mitsuhiro Endoh; Hideki Enomoto; Michela Fagiolini; Lynsey Fairbairn; Hai Fang; Mary C Farach-Carson; Geoffrey J Faulkner; Alexander V Favorov; Malcolm E Fisher; Martin C Frith; Rie Fujita; Shiro Fukuda; Cesare Furlanello; Masaaki Furino; Jun-ichi Furusawa; Teunis B Geijtenbeek; Andrew P Gibson; Thomas Gingeras; Daniel Goldowitz; Julian Gough; Sven Guhl; Reto Guler; Stefano Gustincich; Thomas J Ha; Masahide Hamaguchi; Mitsuko Hara; Matthias Harbers; Jayson Harshbarger; Akira Hasegawa; Yuki Hasegawa; Takehiro Hashimoto; Meenhard Herlyn; Kelly J Hitchens; Shannan J Ho Sui; Oliver M Hofmann; Ilka Hoof; Furni Hori; Lukasz Huminiecki; Kei Iida; Tomokatsu Ikawa; Boris R Jankovic; Hui Jia; Anagha Joshi; Giuseppe Jurman; Bogumil Kaczkowski; Chieko Kai; Kaoru Kaida; Ai Kaiho; Kazuhiro Kajiyama; Mutsumi Kanamori-Katayama; Artem S Kasianov; Takeya Kasukawa; Shintaro Katayama; Sachi Kato; Shuji Kawaguchi; Hiroshi Kawamoto; Yuki I Kawamura; Tsugumi Kawashima; Judith S Kempfle; Tony J Kenna; Juha Kere; Levon M Khachigian; Toshio Kitamura; S Peter Klinken; Alan J Knox; Miki Kojima; Soichi Kojima; Naoto Kondo; Haruhiko Koseki; Shigeo Koyasu; Sarah Krampitz; Atsutaka Kubosaki; Andrew T Kwon; Jeroen F J Laros; Weonju Lee; Andreas Lennartsson; Kang Li; Berit Lilje; Leonard Lipovich; Alan Mackay-Sim; Ri-ichiroh Manabe; Jessica C Mar; Benoit Marchand; Anthony Mathelier; Niklas Mejhert; Alison Meynert; Yosuke Mizuno; David A de Lima Morais; Hiromasa Morikawa; Mitsuru Morimoto; Kazuyo Moro; Efthymios Motakis; Hozumi Motohashi; Christine L Mummery; Mitsuyoshi Murata; Sayaka Nagao-Sato; Yutaka Nakachi; Fumio Nakahara; Toshiyuki Nakamura; Yukio Nakamura; Kenichi Nakazato; Erik van Nimwegen; Noriko Ninomiya; Hiromi Nishiyori; Shohei Noma; Shohei Noma; Tadasuke Noazaki; Soichi Ogishima; Naganari Ohkura; Hiroko Ohimiya; Hiroshi Ohno; Mitsuhiro Ohshima; Mariko Okada-Hatakeyama; Yasushi Okazaki; Valerio Orlando; Dmitry A Ovchinnikov; Arnab Pain; Robert Passier; Margaret Patrikakis; Helena Persson; Silvano Piazza; James G D Prendergast; Owen J L Rackham; Jordan A Ramilowski; Mamoon Rashid; Timothy Ravasi; Patrizia Rizzu; Marco Roncador; Sugata Roy; Morten B Rye; Eri Saijyo; Antti Sajantila; Akiko Saka; Shimon Sakaguchi; Mizuho Sakai; Hiroki Sato; Suzana Savvi; Alka Saxena; Claudio Schneider; Erik A Schultes; Gundula G Schulze-Tanzil; Anita Schwegmann; Thierry Sengstag; Guojun Sheng; Hisashi Shimoji; Yishai Shimoni; Jay W Shin; Christophe Simon; Daisuke Sugiyama; Takaai Sugiyama; Masanori Suzuki; Naoko Suzuki; Rolf K Swoboda; Peter A C 't Hoen; Michihira Tagami; Naoko Takahashi; Jun Takai; Hiroshi Tanaka; Hideki Tatsukawa; Zuotian Tatum; Mark Thompson; Hiroo Toyodo; Tetsuro Toyoda; Elvind Valen; Marc van de Wetering; Linda M van den Berg; Roberto Verado; Dipti Vijayan; Ilya E Vorontsov; Wyeth W Wasserman; Shoko Watanabe; Christine A Wells; Louise N Winteringham; Ernst Wolvetang; Emily J Wood; Yoko Yamaguchi; Masayuki Yamamoto; Misako Yoneda; Yohei Yonekura; Shigehiro Yoshida; Susan E Zabierowski; Peter G Zhang; Xiaobei Zhao; Silvia Zucchelli; Kim M Summers; Harukazu Suzuki; Carsten O Daub; Jun Kawai; Peter Heutink; Winston Hide; Tom C Freeman; Boris Lenhard; Vladimir B Bajic; Martin S Taylor; Vsevolod J Makeev; Albin Sandelin; David A Hume; Piero Carninci; Yoshihide Hayashizaki
Journal:  Nature       Date:  2014-03-27       Impact factor: 49.962

8.  MicroRNA Expression Profile in CAD Patients and the Impact of ACEI/ARB.

Authors:  Martina Weber; Meredith B Baker; Riyaz S Patel; Arshed A Quyyumi; Gang Bao; Charles D Searles
Journal:  Cardiol Res Pract       Date:  2011-07-07       Impact factor: 1.866

9.  MicroRNA-24 regulates macrophage behavior and retards atherosclerosis.

Authors:  Karina Di Gregoli; Nicholas Jenkins; Rebecca Salter; Stephen White; Andrew C Newby; Jason L Johnson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-07-02       Impact factor: 8.311

Review 10.  The emerging landscape of circular RNA in life processes.

Authors:  Shibin Qu; Yue Zhong; Runze Shang; Xuan Zhang; Wenjie Song; Jørgen Kjems; Haimin Li
Journal:  RNA Biol       Date:  2016-08-11       Impact factor: 4.652

View more
  39 in total

1.  Quantification of microRNA editing using two-tailed RT-qPCR for improved biomarker discovery.

Authors:  Gjendine Voss; Anders Edsjö; Anders Bjartell; Yvonne Ceder
Journal:  RNA       Date:  2021-08-25       Impact factor: 4.942

2.  Global MicroRNA Profiling of Vascular Endothelial Cells.

Authors:  Eloi Schmauch; Anna-Liisa Levonen; Suvi Linna-Kuosmanen
Journal:  Methods Mol Biol       Date:  2022

3.  Circular RNA circEsyt2 regulates vascular smooth muscle cell remodeling via splicing regulation.

Authors:  Xue Gong; Miao Tian; Nian Cao; Peili Yang; Zaicheng Xu; Shuo Zheng; Qiao Liao; Caiyu Chen; Cindy Zeng; Pedro A Jose; Da-Zhi Wang; Zhao Jian; Yingbin Xiao; Ding-Sheng Jiang; Xiang Wei; Bing Zhang; Yibin Wang; Ken Chen; Gengze Wu; Chunyu Zeng
Journal:  J Clin Invest       Date:  2021-12-15       Impact factor: 14.808

4.  Exosomes Derived from Mesenchymal Stem Cells Ameliorate the Progression of Atherosclerosis in ApoE-/- Mice via FENDRR.

Authors:  Nan Zhang; Yuxin Luo; Huaping Zhang; Feng Zhang; Xiang Gao; Jiawei Shao
Journal:  Cardiovasc Toxicol       Date:  2022-03-27       Impact factor: 3.231

5.  CircRNA-PTPRA Knockdown Inhibits Atherosclerosis Progression by Repressing ox-LDL-Induced Endothelial Cell Injury via Sponging of miR-671-5p.

Authors:  Xueting Luo; Xiaoli Zhou
Journal:  Biochem Genet       Date:  2022-07-11       Impact factor: 2.220

Review 6.  The role of ferroptosis in endothelial cell dysfunction.

Authors:  Wei Yuan; Hao Xia; Yao Xu; Chong Xu; Nan Chen; Chen Shao; Zhiyin Dai; Rui Chen; Aibin Tao
Journal:  Cell Cycle       Date:  2022-06-14       Impact factor: 5.173

7.  The predictive potential of circulating microRNA for future cardiovascular events.

Authors:  Jason L Johnson
Journal:  Cardiovasc Res       Date:  2021-01-01       Impact factor: 10.787

8.  Differentially expressed mRNAs and their upstream miR-491-5p in patients with coronary atherosclerosis as well as the function of miR-491-5p in vascular smooth muscle cells.

Authors:  Hui Ding; Quanhua Pan; Long Qian; Chuanxian Hu
Journal:  Korean J Physiol Pharmacol       Date:  2022-05-01       Impact factor: 2.016

Review 9.  Circle the Cardiac Remodeling With circRNAs.

Authors:  Tiqun Yang; Tianxin Long; Tailai Du; Yili Chen; Yugang Dong; Zhan-Peng Huang
Journal:  Front Cardiovasc Med       Date:  2021-06-25

Review 10.  Emerging Role of Long Non-Coding RNAs in Diabetic Vascular Complications.

Authors:  Vinay Singh Tanwar; Marpadga A Reddy; Rama Natarajan
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-21       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.